Terms: = Skin cancer AND CD74, ENSG00000019582, 972, protein 41, Ia-GAMMA, HLADG, DHLAG AND Treatment
27 results:
1. Tozasertib activates anti-tumor immunity through decreasing regulatory T cells in melanoma.
Wang Q; Liu W; Zhou H; Lai W; Hu C; Dai Y; Li G; Zhang R; Zhao Y
Neoplasia; 2024 Feb; 48():100966. PubMed ID: 38237304
[TBL] [Abstract] [Full Text] [Related]
2. Comorbidities of Keloid and Hypertrophic Scars Among Participants in UK Biobank.
Ung CY; Warwick A; Onoufriadis A; Barker JN; Parsons M; McGrath JA; Shaw TJ; Dand N
JAMA Dermatol; 2023 Feb; 159(2):172-181. PubMed ID: 36598763
[TBL] [Abstract] [Full Text] [Related]
3. Association of Immune-Related Adverse Events, Hospitalization, and Therapy Resumption With Survival Among Patients With Metastatic Melanoma Receiving Single-Agent or Combination Immunotherapy.
Watson AS; Goutam S; Stukalin I; Ewanchuk BW; Sander M; Meyers DE; Pabani A; Cheung WY; Heng DYC; Cheng T; Monzon JG; Navani V
JAMA Netw Open; 2022 Dec; 5(12):e2245596. PubMed ID: 36480204
[TBL] [Abstract] [Full Text] [Related]
4. Single-cell RNA sequencing unveils the communications between malignant T and myeloid cells contributing to tumor growth and immunosuppression in cutaneous T-cell lymphoma.
Du Y; Cai Y; Lv Y; Zhang L; Yang H; Liu Q; Hong M; Teng Y; Tang W; Ma R; Wu J; Wu J; Wang Q; Chen H; Li K; Feng J
Cancer Lett; 2022 Dec; 551():215972. PubMed ID: 36265653
[TBL] [Abstract] [Full Text] [Related]
5. Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti-CTLA4 and anti-PD1 combination immunotherapy: Incidence, management, and clinical benefit.
Patel AB; Farooq S; Welborn M; Amaria RN; Chon SY; Diab A; Glitza Oliva IC; Huen AO; Li SQ; Nelson KC; Pacha O; Patel SP; Rapini RP; Tawbi HA; Wong MK; McQuade J; Davies MA; Haydu LE
Cancer; 2022 Mar; 128(5):975-983. PubMed ID: 34724197
[TBL] [Abstract] [Full Text] [Related]
6. Beds, overlays and mattresses for preventing and treating pressure ulcers: an overview of Cochrane Reviews and network meta-analysis.
Shi C; Dumville JC; Cullum N; Rhodes S; McInnes E; Goh EL; Norman G
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD013761. PubMed ID: 34398473
[TBL] [Abstract] [Full Text] [Related]
7. Tumor response evaluation in patients with malignant melanoma undergoing immune checkpoint inhibitor therapy and prognosis prediction using
Kitajima K; Watabe T; Nakajo M; Ishibashi M; Daisaki H; Soeda F; Tanemura A; Kanekura T; Yamazaki N; Ito K
Jpn J Radiol; 2022 Jan; 40(1):75-85. PubMed ID: 34287739
[TBL] [Abstract] [Full Text] [Related]
8. Real-world evidence of the safety and effectiveness of regorafenib in Taiwanese patients with metastatic colorectal cancer: CORRELATE Taiwan.
Yeh KH; Yang TS; Hsu TC; Tzu-Liang Chen W; Chen HH; Teng HW; Lin BW; Kuan FC; Chiang FF; Duann CW; Li YS; Lin MT; Fiala-Buskies S; Ducreux M; Wang JY
J Formos Med Assoc; 2021 Nov; 120(11):2023-2031. PubMed ID: 33422398
[TBL] [Abstract] [Full Text] [Related]
9. MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanoma.
de Azevedo RA; Shoshan E; Whang S; Markel G; Jaiswal AR; Liu A; Curran MA; Travassos LR; Bar-Eli M
Oncoimmunology; 2020 Dec; 9(1):1846915. PubMed ID: 33344042
[TBL] [Abstract] [Full Text] [Related]
10. Analysis of Characteristics and Survival of Primary Cutaneous Adenoid Cystic Carcinoma of the Head and Neck.
Behbahani S; Wassef DW; Povolotskiy R; Pinto J; Joseph N; Paskhover B
Ann Otol Rhinol Laryngol; 2021 Jan; 130(1):12-17. PubMed ID: 32567392
[TBL] [Abstract] [Full Text] [Related]
11. Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab.
Yekedüz E; Dursun B; Aydın GÇ; Yazgan SC; Öztürk HH; Azap A; Utkan G; Ürün Y
J Oncol Pharm Pract; 2020 Jul; 26(5):1289-1294. PubMed ID: 32423324
[TBL] [Abstract] [Full Text] [Related]
12. Testing the feasibility of augmented digital skin imaging to objectively compare the efficacy of topical treatments for radiodermatitis.
Partl R; Lehner J; Winkler P; Kapp KS
PLoS One; 2019; 14(6):e0218018. PubMed ID: 31181091
[TBL] [Abstract] [Full Text] [Related]
13. Macrophage migration inhibitory factor-cd74 interaction regulates the expression of programmed cell death ligand 1 in melanoma cells.
Imaoka M; Tanese K; Masugi Y; Hayashi M; Sakamoto M
Cancer Sci; 2019 Jul; 110(7):2273-2283. PubMed ID: 31069878
[TBL] [Abstract] [Full Text] [Related]
14. skin cancer precursor immunotherapy for squamous cell carcinoma prevention.
Rosenberg AR; Tabacchi M; Ngo KH; Wallendorf M; Rosman IS; Cornelius LA; Demehri S
JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30895944
[TBL] [Abstract] [Full Text] [Related]
15. Nonmelanoma skin cancer risk awareness in azathioprine-treated myasthenia gravis patients.
McGurgan IJ; McGuigan C
Brain Behav; 2015 Oct; 5(10):e00396. PubMed ID: 26516615
[TBL] [Abstract] [Full Text] [Related]
16. Specialized surveillance for individuals at high risk for melanoma: a cost analysis of a high-risk clinic.
Watts CG; Cust AE; Menzies SW; Coates E; Mann GJ; Morton RL
JAMA Dermatol; 2015 Feb; 151(2):178-86. PubMed ID: 25389712
[TBL] [Abstract] [Full Text] [Related]
17. Melanoma associated with tumour necrosis factor-α inhibitors: a Research on Adverse Drug events And Reports (RADAR) project.
Nardone B; Hammel JA; Raisch DW; Weaver LL; Schneider D; West DP
Br J Dermatol; 2014 May; 170(5):1170-2. PubMed ID: 24328939
[TBL] [Abstract] [Full Text] [Related]
18. Prevalence of human Papillomavirus DNA in eyebrow hairs plucked from patients with psoriasis treated with TNF inhibitors.
Bellaud G; Gheit T; Pugin A; Prétet JL; Tommasino M; Mougin C; Aubin F
J Eur Acad Dermatol Venereol; 2014 Dec; 28(12):1816-20. PubMed ID: 24206262
[TBL] [Abstract] [Full Text] [Related]
19. cancer risk of anti-TNF-α at recommended doses in adult rheumatoid arthritis: a meta-analysis with intention to treat and per protocol analyses.
Moulis G; Sommet A; Béné J; Montastruc F; Sailler L; Montastruc JL; Lapeyre-Mestre M
PLoS One; 2012; 7(11):e48991. PubMed ID: 23155441
[TBL] [Abstract] [Full Text] [Related]
20. [Eyelid melanoma: our experience a propos of 23 cases].
Kostopoulos E; Champsas G; Konofaos P; Kostaki M; Papadopoulos O
Ann Chir Plast Esthet; 2012 Apr; 57(2):158-63. PubMed ID: 21840104
[TBL] [Abstract] [Full Text] [Related]
[Next]
